Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
- 23 July 1987
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 317 (4) , 249-251
- https://doi.org/10.1056/nejm198707233170416
Abstract
Correspondence from The New England Journal of Medicine — Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinKeywords
This publication has 11 references indexed in Scilit:
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986
- Patients surviving 10 years of hemodialysisThe American Journal of Medicine, 1983
- Urea movement across erythrocyte membrane during artificial kidney treatmentKidney International, 1983
- A Comparison of Androgens for Anemia in Patients on HemodialysisNew England Journal of Medicine, 1981
- Controlled Study of Androgen Therapy in Anemia of Patients on Maintenance HemodialysisNew England Journal of Medicine, 1974
- Nandrolone Decanoate Therapy for Patients Receiving HemodialysisArchives of internal medicine (1960), 1974
- Transcellular Creatinine Disequilibrium and its Significance in HemodialysisNephron, 1974
- Androgens and ErythropoiesisNew England Journal of Medicine, 1973
- OXYMETHOLONE IN THE TREATMENT OF ANAEMIA IN CHRONIC RENAL FAILUREBritish Journal of Urology, 1972